Skip to main content

4 Result(s)

within Naokazu Nakamura Remove this filter

and

  1. No Access

    Article

    KyoTox-e score; prediction of post-CAR-T prolonged thrombocytopenia using peripheral blood data before apheresis

    Tomoyasu Jo, Yasuyuki Arai, Toshio Kitawaki… in Bone Marrow Transplantation (2024)

  2. No Access

    Article

    Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study

    Elotuzumab-based regimens are sometimes selected for multiple myeloma treatment after daratumumab-based regimens. However, there has been insufficient discussion on the efficacy of elotuzumab after daratumumab...

    Naokazu Nakamura, Nobuyoshi Arima, Teruhito Takakuwa… in Annals of Hematology (2024)

  3. Article

    Open Access

    Utilizing red blood cell distribution width (RDW) as a reliable biomarker to predict treatment effects after chimeric antigen receptor T cell therapy

    Chimeric antigen receptor T cell (CAR-T) therapy is an effective treatment for B cell malignancies. A certain fraction of patients, however, experience post-CAR-T relapse, and due to the difficulty of precise ...

    Naokazu Nakamura, Tomoyasu Jo, Yasuyuki Arai… in Clinical and Experimental Medicine (2024)

    Download PDF (773 KB) View Article

  4. No Access

    Article

    Sustained remission after cord blood transplantation for breast cancer with lung metastases and myelodysplastic syndrome

    Allogenic hematopoietic stem cell transplantation (allo-HSCT) is not a standard therapy for solid cancer because of its high toxicity and insufficient evidence levels. However, the potential graft-versus-solid...

    Naokazu Nakamura, Nao Yamamoto, Tadakazu Kondo… in International Journal of Hematology (2024)